-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Upgrades Iovance Biotherapeutics to Market Outperform, Announces $5 Price Target

Benzinga·03/03/2026 13:44:27
Listen to the news
Citizens analyst Reni J. Benjamin upgrades Iovance Biotherapeutics (NASDAQ:IOVA) from Market Perform to Market Outperform and announces $5 price target.